Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 2.46% for the current model date.
BlackTreeCVE Intelligenceopen source · OpenClinic GA
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedOpenClinic GA 5.09.02 and 5.89.05b includes arbitrary local files specified within its parameter and executes some files, which may allow disclosure of sensitive files or the execution of malicious uploaded files.
OpenClinic GA 5.09.02 and 5.89.05b includes arbitrary local files specified within its parameter and executes some files, which may allow disclosure of sensitive files or the execution of malicious uploaded files.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
OpenClinic GA 5.09.02 and 5.89.05b includes arbitrary local files specified within its parameter and executes some files, which may allow disclosure of sensitive files or the execution of malicious uploaded files.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'). The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 29 Jul 2020 · Last source change 16 Sept 2024, 17:03 UTC · CWE-22 · Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Core structured fields are present and their contributing authorities are shown above.
No material field changes have been recorded since change tracking began. Routine source refreshes and cosmetic edits are intentionally excluded.